"The next decade will witness an increasing number of clinical trials that seek to translate preclinical research discoveries to the clinic. Promising drug- or cell-based therapeutic approaches include erythropoietin and its carbamylated form, statins, bone marrow stromal cells, stem cells singularly or in combination or with biomaterials to reduce brain injury via neuroprotection and promote brain remodeling via angiogenesis, neurogenesis, and synaptogenesis with a final goal to improve functional outcome of [traumatic brain injury] patients."
Since the death of actress Natasha Richardson, there has been much public interest in brain injury.
Created by Brad Roth (roth@oakland.edu) on Thursday, April 16, 2009 Modified by Brad Roth (roth@oakland.edu) on Thursday, April 16, 2009 Article Start Date: Thursday, April 16, 2009
